Skip to main content
Caplight Logo









Lucine

Lucine

Private
BordeauxHealthcare & Life Scienceshttps://projet-lucine.com

Last Round

Seed

Nov 18, 2020

Total Funding Raised

$6.5M

Company Overview

Lucine operates in Healthcare & Life Sciences and is based in Bordeaux. Its latest recorded funding round was a Seed round in November 2020.

Lucine is a digital therapeutics company that develops mobile health applications designed to measure, analyze, and relieve chronic pain.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Lucine Comparables

Compare Lucine with similar companies based on industry and business-model similarity.

Lucine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AppliedVR
78%
Curable
76%
Moonai
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Lucine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Lucine Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2020

    $6.5M raised from Aquiti Gestion, BNP Paribas, and others.

Book a demo to see all signals

For institutional investors. Book with your work email.

Lucine Filings

Explore SEC and related filing metadata, where available.

Lucine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Lucine's valuation, stock price, and market status.

Is Lucine a public or private company?

Lucine is a private company.

What is the current stock price of Lucine?

Lucine is a private company, so its shares have no public market price. Caplight tracks Lucine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Lucine worth (valuation)?

Valuation information for Lucine is not publicly available.

Can I buy Lucine stock?

Lucine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Lucine's last funding round?

Lucine's most recent funding round was Seed on November 18, 2020.

Who are the main investors in Lucine?

Key investors in Lucine include BNP Paribas Développement, Aquiti Gestion, IRDI Soridec Gestion, Bpifrance, Kurma Partners.

Will Lucine IPO soon?

No public IPO plans have been announced for Lucine.

How can I track Lucine secondary market activity?

Caplight tracks bids, offers, and trades in Lucine's shares on secondary markets.

Firmographic Details

HeadquartersBordeaux
Year Founded2017
Last FundingNov 18, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?